Ultrasound-Guided Paracentesis in Cirrhosis: Bleeding Risk, Coagulopathy, and Routine Pre-Procedure Transfusion

Abstract

Paracentesis is the most frequently performed invasive procedure in patients with cirrhosis, and because these patients commonly present with a prolonged international normalized ratio and thrombocytopenia, many clinicians still transfuse fresh frozen plasma or platelets before the procedure in the belief that this prevents bleeding. This practice rests on an older view of liver disease as a simple bleeding disorder, a view that modern understanding of rebalanced hemostasis has largely overturned. This review examined whether routine pre-procedure transfusion is justified when paracentesis is performed under ultrasound guidance, and what should replace it. A structured narrative synthesis was undertaken of observational studies, randomized trials, systematic reviews, and practice guidance on adults with chronic liver disease, supplemented by health-systems literature to address implementation, and the certainty of the main conclusions was graded qualitatively.
The evidence shows that major bleeding after paracentesis is uncommon, affecting well under one percent of procedures in most settings, and that it remains uncommon even in patients whose coagulation results would traditionally have been considered prohibitive. Conventional coagulation tests do not identify the patients who bleed, because cirrhosis lowers procoagulant and anticoagulant factors together and the international normalized ratio measures only one side of that balance. Prophylactic plasma and platelets have no demonstrated benefit, seldom correct the laboratory values they target, and expose patients to circulatory overload, lung injury, rising portal pressure, and delay in a procedure whose timeliness itself influences survival. Risk is better captured by the clinical context, particularly acute kidney injury, advanced liver failure, and acute-on-chronic liver failure, while viscoelastic testing offers a more physiological guide that reduces blood product use without increasing bleeding. The intervention most consistently associated with safer practice is procedural rather than haematological: ultrasound guidance, scanning of the needle tract for abdominal wall vessels, and well-trained operators substantially reduce bleeding complications. Translating this evidence into practice depends on the wider health system, including access to ultrasound and reliable laboratories, secure supplies of blood products and albumin, workforce training, and routine audit, considerations that weigh most heavily in resource-limited settings. Routine measurement and correction of coagulation tests before ultrasound-guided paracentesis in cirrhosis is therefore not supported, and clinical effort is better directed toward prompt, image-guided procedures, careful recognition of genuinely high-risk patients, and the system-level conditions that allow transfusion-sparing care to become standard practice.